RavenQuest BioMed Inc. announced earnings results for the third quarter ended July 31, 2019. For the third quarter, the company announced total revenue was CAD 709,642 compared to CAD 171,853 a year ago. Net loss was CAD 3.124 million compared to CAD 3.184 million a year ago. Basic loss per share was CAD 0.03 compared to CAD 0.03 a year ago. For the nine months, total revenue was CAD 1.662 million compared to CAD 1.397 million a year ago. Net loss was CAD 9.523 million compared to CAD 7.641 million a year ago. Basic loss per share was CAD 0.08 compared to CAD 0.08 a year ago.